文献速递外周动脉疾病

血栓闭塞性脉管炎合并慢性肢体威胁性缺血:开放手术与腔内血运重建的系统评价与荟萃分析

Open Surgical Versus Endovascular Revascularization in Thromboangitis Obliterans Patients with Chronic Limb Threatening Ischemia - A Systematic Review and Metanalysis.
PubMed 文献 · Ann Vasc Surg · 2026-03-24

该系统评价与荟萃分析比较了血栓闭塞性脉管炎(TAO)合并慢性肢体威胁性缺血(CLTI)患者接受开放手术与腔内血运重建的结局。纳入4项研究共150例患者(腔内81例,开放手术69例),发现两组在保肢、技术失败、临床改善及1年和3年二期通畅率方面无显著差异,但开放手术组6个月一期通畅率显著更高,腔内治疗组1年再干预率显著更高。

要点

  • TAO合并CLTI患者中,开放手术与腔内治疗的保肢效果相当。
  • 开放手术6个月一期通畅率显著优于腔内治疗(汇总估计0.63,95%CI 0.48-0.82)。
  • 腔内治疗1年再干预率显著更高(汇总估计2.15,95%CI 1.34-3.44)。

核心结论

  • TAO合并CLTI患者中,开放手术与腔内血运重建的保肢结局相当。
  • 腔内治疗早期一期通畅率较低且1年再干预率较高,选择血运重建策略时应考虑这些因素。

研究设计与样本

  • 系统评价与荟萃分析,遵循PRISMA指南,检索PubMed、Google Scholar和Scopus(2024年2月15日)。
  • 纳入4项比较开放手术与腔内血运重建的研究,共150例患者(腔内81例,开放手术69例)。
  • 采用随机效应模型进行荟萃分析。

主要发现

  • 两组在保肢、技术失败、临床改善及1年和3年二期通畅率方面无显著差异。
  • 开放手术组6个月一期通畅率显著更高,汇总估计为0.63(95%CI 0.48-0.82)。
  • 腔内治疗组1年再干预率显著更高,汇总估计为2.15(95%CI 1.34-3.44)。

关键数值与推荐

  • 纳入研究需全文可用,并报告保肢、通畅率、技术失败、临床改善或再干预结局。

临床怎么用

  • 对于TAO合并CLTI患者,开放手术可能提供更好的早期一期通畅率。
  • 选择腔内治疗时应预期更高的再干预风险,需加强随访监测。

局限性

  • 仅纳入4项研究共150例患者,样本量有限。
  • 原文未报告纳入研究的偏倚风险或异质性评估细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: More than 100 years have passed since Leo Buerger first described thromboangiitis obliterans (TAO). The incidence and prevalence of the disease have since declined, yet TAO remains a challenging condition to treat. Historically, surgical bypass has been the primary revascularization method, while in the past decade, endovascular techniques have increasingly been applied for chronic limb-threatening ischemia (CLTI) in TAO patients. However, comparative outcome data for these 2 strategies remain limited. METHODS: PubMed, Google Scholar, and Scopus were searched on February 15, 2024, for studies comparing surgical and endovascular revascularization in TAO. A systematic review was conducted following PRISMA guidelines using predefined MeSH terms. Studies with full text available that reported limb salvage, patency, technical failure, clinical improvement, or reintervention outcomes were included. Meta-analysis was performed using a random-effects model. RESULTS: Four studies involving 150 patients (81 endovascular; 69 surgical bypass) met inclusion criteria. No significant differences were observed between groups in limb salvage, technical failure, clinical improvement, or secondary patency at 1 and 3 years. Early (6-month) primary patency was significantly higher in the surgical bypass group, with a pooled estimate of 0.63 (95% CI 0.48-0.82). Endovascular treatment was associated with a significantly higher 1-year reintervention rate (pooled estimate 2.15; 95% CI 1.34-3.44). CONCLUSION: Limb salvage outcomes were comparable between surgical and endovascular approaches. However, endovascular interventions demonstrated lower early primary patency and higher reintervention rates in TAO patients presenting with CLTI. These factors should be carefully considered when selecting a revascularization strategy for this patient population.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jagan Sebastian J, Pawar P. Open Surgical Versus Endovascular Revascularization in Thromboangitis Obliterans Patients with Chronic Limb Threatening Ischemia - A Systematic Review and Metanalysis. Ann Vasc Surg. 2026. PMID: 41887323. doi:10.1016/j.avsg.2026.03.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。